Press Releases :: VolitionRx Ltd (VNRX)

May 18, 2015 8:00 am EDT

VolitionRx CEO Cameron Reynolds to Present Informational Webinar

May 12, 2015 7:50 am EDT

VolitionRx Announces First Quarter 2015 Financial Results and Business Update

May 8, 2015 8:00 am EDT

VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ® Assays in Most Prevalent Cancers

May 6, 2015 8:00 am EDT

VolitionRx Schedules First Quarter 2015 Earnings Conference Call and Business Update for Tuesday, May 12, 2015 at 8:30 a.m. ET

Apr 21, 2015 8:00 am EDT

VolitionRx Initiates Study with Hvidovre Hospital, Denmark, Specifically to Target NuQ(R) Biomarker Panel for Colorectal Polyps

Apr 9, 2015 8:00 am EDT

VolitionRx Adds Three New Laboratory Automation Systems to Expedite Sample Analysis for its Large Ongoing Clinical Trials

Mar 5, 2015 8:00 am EST

VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology

Feb 24, 2015 8:00 am EST

VolitionRx Acquires Direct Ownership of Nucleosomics® Technology Patent

Feb 17, 2015 8:00 am EST

VolitionRx Limited Announces Exercise of Over-Allotment Option in Previously Announced Public Offering

Feb 12, 2015 8:00 am EST

VolitionRx Limited Announces Closing of Public Offering of Common Stock

rss_feed News RSS